TD52（Cat No.:I044514）is a synthetic small-molecule compound known for its role in modulating transcription factors, particularly STAT3 (Signal Transducer and Activator of Transcription 3), which is frequently dysregulated in various cancers. By inhibiting STAT3 activity, TD52 disrupts the expression of genes involved in cell survival, proliferation, and immune evasion. It has demonstrated potent anti-tumor effects in preclinical models, including hepatocellular carcinoma and other malignancies, by promoting apoptosis and reducing tumor growth. TD52 is valuable for exploring targeted cancer therapies and understanding the molecular mechanisms underlying oncogenic transcriptional regulation.